Literature DB >> 24304668

Evidence for the presence of lipid-free monomolecular apolipoprotein A-1 in plasma.

Osamu Miyazaki1, Jun Ogihara, Isamu Fukamachi, Takafumi Kasumi.   

Abstract

The first step in reverse cholesterol transport is a process by which lipid-free or lipid-poor apoA-1 removes cholesterol from cells through the action of ATP binding cassette transporter A1 at the plasma membrane. However the structure and composition of lipid-free or -poor apoA-1 in plasma remains obscure. We previously obtained a monoclonal antibody (MAb) that specifically recognizes apoA-1 in preβ1-HDL, the smallest apoA-1-containing particle in plasma, which we used to establish a preβ1-HDL ELISA. Here, we purified preβ1-HDL from fresh normal plasma using said antibody, and analyzed the composition and structure. ApoA-1 was detected, but neither phospholipid nor cholesterol were detected in the purified preβ1-HDL. Only globular, not discoidal, particles were observed by electron microscopy. In nondenaturing PAGE, no difference in the mobility was observed between the purified preβ1-HDL and original plasma preβ1-HDL, or between the preβ1-HDL and lipid-free apoA-1 prepared by delipidating HDL. In sandwich ELISA using two anti-preβ1-HDL MAbs, reactivity with intact plasma preβ1-HDL was observed in ELISA using two MAbs with distinct epitopes but no reactivity was observed in ELISA using a single MAb, and the same phenomenon was observed with monomolecular lipid-free apoA-1. These results suggest that plasma preβ1-HDL is lipid-free monomolecular apoA-1.

Entities:  

Keywords:  lipid-free apolipoprotein A-1; pre-beta-high density lipoprotein; reverse cholesterol transport

Mesh:

Substances:

Year:  2013        PMID: 24304668      PMCID: PMC3886660          DOI: 10.1194/jlr.M041038

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  50 in total

Review 1.  ABCA1. The gatekeeper for eliminating excess tissue cholesterol.

Authors:  J F Oram; R M Lawn
Journal:  J Lipid Res       Date:  2001-08       Impact factor: 5.922

2.  Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein.

Authors:  G R Castro; C J Fielding
Journal:  Biochemistry       Date:  1988-01-12       Impact factor: 3.162

3.  Biochemical and physical properties of remnant-HDL2 and of pre beta 1-HDL produced by hepatic lipase.

Authors:  K Guendouzi; B Jaspard; R Barbaras; C Motta; C Vieu; Y Marcel; H Chap; B Perret; X Collet
Journal:  Biochemistry       Date:  1999-03-02       Impact factor: 3.162

4.  Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease.

Authors:  B F Asztalos; M E Brousseau; J R McNamara; K V Horvath; P S Roheim; E J Schaefer
Journal:  Atherosclerosis       Date:  2001-05       Impact factor: 5.162

5.  Formation of prebeta1-HDL during lipolysis of triglyceride-rich lipoprotein.

Authors:  Osamu Miyazaki; Isamu Fukamachi; Atsuo Mori; Hideyuki Hashimoto; Masa-aki Kawashiri; Atsushi Nohara; Tohru Noguchi; Akihiro Inazu; Masakazu Yamagishi; Hiroshi Mabuchi; Junji Kobayashi
Journal:  Biochem Biophys Res Commun       Date:  2008-12-12       Impact factor: 3.575

Review 6.  Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I.

Authors:  Kerry-Anne Rye; Philip J Barter
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-30       Impact factor: 8.311

7.  Probucol markedly reduces HDL phospholipids and elevated prebeta1-HDL without delayed conversion into alpha-migrating HDL: putative role of angiopoietin-like protein 3 in probucol-induced HDL remodeling.

Authors:  Takashi Miida; Utako Seino; Osamu Miyazaki; Osamu Hanyu; Satoshi Hirayama; Toshikazu Saito; Yuichi Ishikawa; Suguru Akamatsu; Toshimitsu Nakano; Katsuyuki Nakajima; Mitsuyo Okazaki; Masahiko Okada
Journal:  Atherosclerosis       Date:  2008-02-14       Impact factor: 5.162

8.  Determination of the structural domain of ApoAI recognized by high density lipoprotein receptors.

Authors:  J Morrison; N H Fidge; M Tozuka
Journal:  J Biol Chem       Date:  1991-10-05       Impact factor: 5.157

9.  Characterization of dog peripheral lymph lipoproteins: the presence of a disc-shaped "nascent" high density lipoprotein.

Authors:  C H Sloop; L Dory; R Hamilton; B R Krause; P S Roheim
Journal:  J Lipid Res       Date:  1983-11       Impact factor: 5.922

10.  Unique epitope of apolipoprotein A-I expressed in pre-beta-1 high-density lipoprotein and its role in the catalyzed efflux of cellular cholesterol.

Authors:  P E Fielding; M Kawano; A L Catapano; A Zoppo; S Marcovina; C J Fielding
Journal:  Biochemistry       Date:  1994-06-07       Impact factor: 3.162

View more
  14 in total

1.  Evacetrapib reduces preβ-1 HDL in patients with atherosclerotic cardiovascular disease or diabetes.

Authors:  Yunqin Chen; Jibin Dong; Xiaojin Zhang; Xueying Chen; Li Wang; Haozhu Chen; Junbo Ge; Xian-Cheng Jiang
Journal:  Atherosclerosis       Date:  2019-04-14       Impact factor: 5.162

Review 2.  Structural stability and functional remodeling of high-density lipoproteins.

Authors:  Olga Gursky
Journal:  FEBS Lett       Date:  2015-03-05       Impact factor: 4.124

3.  Oxidation of methionine residues in human apolipoprotein A-I generates a potent pro-inflammatory molecule.

Authors:  Andrzej Witkowski; Sonia Carta; Rui Lu; Shinji Yokoyama; Anna Rubartelli; Giorgio Cavigiolio
Journal:  J Biol Chem       Date:  2019-01-11       Impact factor: 5.157

4.  Triglyceride increase in the core of high-density lipoproteins augments apolipoprotein dissociation from the surface: Potential implications for treatment of apolipoprotein deposition diseases.

Authors:  Shobini Jayaraman; Jose Luis Sánchez-Quesada; Olga Gursky
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-10-18       Impact factor: 5.187

5.  A Fluorescence-Based In Vitro Method to Assess Cholesterol Efflux.

Authors:  Sara Fernández-Castillejo; Anna Pedret; Úrsula Catalán Santos; Rosa Solà
Journal:  Methods Mol Biol       Date:  2022

6.  Proteolysis of apolipoprotein A-I by secretory phospholipase A₂: a new link between inflammation and atherosclerosis.

Authors:  Giorgio Cavigiolio; Shobini Jayaraman
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

Review 7.  Dysfunctional HDL and atherosclerotic cardiovascular disease.

Authors:  Robert S Rosenson; H Bryan Brewer; Benjamin J Ansell; Philip Barter; M John Chapman; Jay W Heinecke; Anatol Kontush; Alan R Tall; Nancy R Webb
Journal:  Nat Rev Cardiol       Date:  2015-09-01       Impact factor: 32.419

8.  Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro.

Authors:  Anouar Hafiane; John K Bielicki; Jan O Johansson; Jacques Genest
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

9.  Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size.

Authors:  Herman J Kempen; Dorota B Schranz; Bela F Asztalos; James Otvos; Elias Jeyarajah; Denise Drazul-Schrader; Heidi L Collins; Steven J Adelman; Peter L J Wijngaard
Journal:  J Lipids       Date:  2014-11-12

10.  A model of lipid-free apolipoprotein A-I revealed by iterative molecular dynamics simulation.

Authors:  Xing Zhang; Dongsheng Lei; Lei Zhang; Matthew Rames; Shengli Zhang
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.